Metraipolis › archive › dc_056b60ade4c4
Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis — Europe PMC PMID:42069951
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42069951
- DOI
- 10.1038/s41598-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T19:19:27.303Z
- SHA-256 of the archived text
640b9ac27352065be85b4a3058d46d51df5f9830563437346401a5b7f2847396- Stable URL of this page
https://metraipolis.com/documento/dc_056b60ade4c4
How to cite
Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis — Europe PMC PMID:42069951 — Europe PMC (en), https://europepmc.org/article/MED/42069951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_056b60ade4c4 (Metraipolis archive dc_056b60ade4c4, sha256 640b9ac27352065be85b4a3058d46d51df5f9830563437346401a5b7f2847396)
BibTeX
@misc{dc056b60ade4c4,
title = {Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis — Europe PMC PMID:42069951},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42069951},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_056b60ade4c4; sha256 640b9ac27352065be85b4a3058d46d51df5f9830563437346401a5b7f2847396},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42069951. Agents can read the archived copy with the MCP tool read_document.